That treatment, called CAR-T therapy, had been a groundbreaking step forward for cancer patients.
In MS trials, investigators are steering those cells toward B‑cell populations that appear to be driving inflammation.
What seemed like a simple illness turned into a life-changing diagnosis for Debi Weiss, a 72-year-old Pilates instructor who later discovered she had an aggressive form of cancer. Her journey through ...